Healthcare - Biotechnology - NASDAQ - US
$ 42.18
-15.6 %
$ 5.03 B
Market Cap
-14.65
P/E
CASH FLOW STATEMENT
-119 M
OPERATING CASH FLOW
-130 M
INVESTING CASH FLOW
93.9 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Avidity Biosciences, Inc.
| Net Income | -212 M |
| Depreciation & Amortization | 2.1 M |
| Capital Expenditures | -4.23 M |
| Stock-Based Compensation | 38.2 M |
| Change in Working Capital | 61.1 M |
| Others | 51.1 M |
| Free Cash Flow | -123 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||
| Net Income | (212.2) | (174.0) | (118.0) | (44.4) | (24.7) | (11.2) |
| Depreciation & Amortization | 2.1 | 1.4 | 0.6 | 0.4 | 0.3 | 0.4 |
| Deferred Income Tax | 0 | 0 | 0 | 84 K | 0 | 0 |
| Stock Based Compensation | 38.2 | 27.1 | 17.1 | 4.3 | 0.4 | 60 K |
| Other Operating Activities | (8.3) | (0.6) | 0.2 | 0.1 | 7.3 | 0.4 |
| Change in Working Capital | 61.1 | 9.8 | 5.3 | 2.3 | 19.1 | 0.7 |
| Cash From Operations | (119.1) | (136.3) | (94.8) | (37.1) | 2.5 | (9.7) |
| INVESTING CASH FLOW | ||||||
| Capital Expenditures | (4.2) | (2.8) | (3.7) | (1.1) | (0.2) | 49 K |
| Other Items | (125.8) | (187.1) | (78.8) | (6.7) | 0 | 0 |
| Cash From Investing Activities | (130.1) | (190.0) | (82.5) | (7.8) | (0.2) | 49 K |
| FINANCING CASH FLOW | ||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | (4.7) | 16.7 | 5.0 |
| Dividends Paid | 0 | 0 | 0 | 0 | (0.1) | 0 |
| Other Financing Activities | 33.3 | 1.4 | 1.6 | 2.7 | 72.7 | 0.2 |
| Cash From Financing Activities | 93.9 | 346.2 | 176.3 | 272.0 | 89.2 | 5.1 |
| CHANGE IN CASH | ||||||
| Net Change In Cash | (155.3) | 19.9 | (1.0) | 227.1 | 91.5 | (4.6) |
| FREE CASH FLOW | ||||||
| Free Cash Flow | (123.3) | (139.1) | (98.6) | (38.2) | 2.3 | (9.7) |